The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

Seventh Annual Gastrointestinal Cancers Symposium Press Program Announced


FOR IMMEDIATE RELEASE:
January 6, 2010

CONTACT: Aaron Tallent
571-483-1371
aaron.tallent@asco.org

Presscast on January 20, 12:00 PM EST


ALEXANDRIA, Va. – Four studies from the seventh annual Gastrointestinal (GI) Cancers Symposium Press Program will be highlighted in an embargoed presscast (press briefing via live webcast) on Wednesday, January 20, from 12:00-1:30 PM (EST). The featured studies will focus on advances in the detection and treatment of colorectal, gastric and pancreatic cancers.

During the presscast, researchers will present four featured studies, including:

  • Findings on the effectiveness of a simple CD24 blood test for detecting colorectal cancer and polyps. CD24 is a protein involved in colorectal cancer cell adhesion and metastasis.
  • Results of a study evaluating the PAM4 antibody assay for detecting early-stage pancreatic cancer.
  • A randomized, phase III trial evaluating the effectiveness of capecitabine (Xeloda) and oxaliplatin (Eloxatin) with 5-fluorouracil plus leucovorin (5-FU/LV) for stage III colon cancer; the study also assessed whether treatment efficacy is influenced by patient age.
  • A study examining the influence of a variation in the CD44 gene on clinical outcome in people with localized gastric cancer.

This year’s Symposium will take place from January 22 through January 24, 2010, at the Orlando World Center Marriott in Florida, and will feature more than 500 abstracts on a variety of gastrointestinal cancers including cancers of the esophagus, stomach, hepatobiliary, pancreas, small bowel, colon, and rectum. There are approximately 275,000 cases and more than 135,000 deaths due to these cancers in the U.S. every year.

Four leading medical specialty societies co-sponsor the three-day, multidisciplinary symposium, including the American Gastroenterological Association (AGA), the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO) and the Society of Surgical Oncology (SSO).

News Room: In addition to the presscast, a working news room will be available onsite at the meeting for reporters. Experts will be available for comment and perspective upon request.

Registration: To register to attend the meeting, visit www.asco.org/GIpresskit10 or contact Kelly Powell at kelly.powell@asco.org or 571-483-1365.

# # #





 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2011 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.
Feedback Form